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ARTICLE
Optical tissue clearing and machine learning can
precisely characterize extravasation and blood
vessel architecture in brain tumors
Serhii Kostrikov 1, Kasper B. Johnsen1, Thomas H. Braunstein2, Johann M. Gudbergsson1,3,
Frederikke P. Fliedner4,5, Elisabeth A. A. Obara6,7, Petra Hamerlik6, Anders E. Hansen1, Andreas Kjaer 4,5,
Casper Hempel 1✉ & Thomas L. Andresen 1✉
Precise methods for quantifying drug accumulation in brain tissue are currently very limited,
challenging the development of new therapeutics for brain disorders. Transcardial perfusion
is instrumental for removing the intravascular fraction of an injected compound, thereby
allowing for ex vivo assessment of extravasation into the brain. However, pathological
remodeling of tissue microenvironment can affect the efficiency of transcardial perfusion,
which has been largely overlooked. We show that, in contrast to healthy vasculature,
transcardial perfusion cannot remove an injected compound from the tumor vasculature to a
sufficient extent leading to considerable overestimation of compound extravasation. We
demonstrate that 3D deep imaging of optically cleared tumor samples overcomes this lim-
itation. We developed two machine learning-based semi-automated image analysis work-
flows, which provide detailed quantitative characterization of compound extravasation
patterns as well as tumor angioarchitecture in large three-dimensional datasets from optically
cleared samples. This methodology provides a precise and comprehensive analysis of
extravasation in brain tumors and allows for correlation of extravasation patterns with spe-
cific features of the heterogeneous brain tumor vasculature.
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The blood–brain barrier (BBB) is the most impermeable andselective barrier of the human body. This makes assess-ment of drug accumulation in the brain particularly
challenging, since only low drug concentration can usually be
expected in the brain parenchyma1. Transcardial perfusion is a
technique widely used to clear out the intravascular fraction of
the injected compound prior to harvesting tissue samples2. This
theoretically allows for reducing the contribution from the cir-
culating drug present in the vasculature in bulk measurements,
hereby enabling a quantification of extravasated drug exclu-
sively. Different cerebral pathologies are characterized by a
varying degree of vasculature and microenvironment remodel-
ing, which may result in an impairment of the regional blood
circulation3,4. Such remodeling is particularly pronounced in
brain tumors like glioblastoma (GBM)5. Nevertheless, its impact
on the validity of drug accumulation measurements has gone by
unrecognized.
GBM is the most malignant type of brain tumor, and, despite
intensive research, it’s curative treatment remains a challenge6.
The current first-line GBM treatment strategy, consisting of MRI-
guided radical resection with subsequent chemo- and radio-
therapy, provides a median survival time of ~15 months from the
time of diagnosis7,8. Due to the high invasiveness of GBM cells
and their ability to migrate in brain parenchyma, complete tumor
resection is impossible9,10. Furthermore, high cellular hetero-
geneity provides a solid foundation for tumor multidrug resis-
tance, which, coupled with active angiogenesis, results in fast
tumor regrowth despite intensive therapeutic pressure9,11. The
heterogeneity of GBM blood–tumor barrier (BTB) both with
regard to permeability and surface marker profile coupled with
inherent cellular plasticity also complicate the development of
new treatment strategies12. Another factor complicating ther-
apeutic intervention is the intermittent blood circulation in the
tumor vasculature, which makes only a part of tumor vessels
accessible for the drug at a given time point5,13.
In order to understand the performance of a drug in such an
abnormal and heterogeneous environment, precise methods for
evaluating compound extravasation and its spatial distribution
are needed11,14. Nevertheless, numerous techniques used for
this purpose are rather limited in many ways. For example,
inductive coupled plasma mass spectrometry (ICP-MS) or high-
performance liquid chromatography (HPLC) provide a precise
quantitative measure of compound accumulation only at a
macroscopic level15,16, i.e., no spatial details are obtained.
Microscopy-based techniques, on the other hand, have lower
quantitative precision and throughput, but provide insights into
spatial distribution of the compound and its correlation with
features of the tumor microenvironment17,18. The drawback of
the conventional microscopy, however, is that achieving a broad
spatial coverage of different GBM regions is challenging due to
the need of tissue sectioning. Another important point of con-
sideration is the fact that the precision of multiple methods used
for extravasation assessment depends on successful removal of
the intravascular fraction of the injected compound by trans-
cardial perfusion2,19–21.
In the present study, we investigated the phenomenon of
transcardial perfusion deficiency in brain tumor vessels, and show
that the current methodology of compound extravasation ana-
lyses in brain tumors have considerable limitations. As a solution
to this, we show the potential of 3D deep tissue imaging for such
analysis, and describe machine learning-based image analysis
workflows that enable reliable quantification and spatial mapping
of compound extravasation, as well as the ability to correlate
compound extravasation to the regional characteristics of the
GBM angioarchitecture.
Results
Transcardial perfusion is inefficient in removing injected
compounds from GBM vessels. For the initial examination of
transcardial perfusion efficiency in GBM vasculature, we
employed transmission electron microscopy of perfusion-fixed
samples of GBM from two orthotropic xenograft models, origi-
nating from primary patient-derived GBM cells. The examination
revealed tumor vessels filled with erythrocytes (Fig. 1a–c), sug-
gesting inefficient perfusion in the GBM vasculature. This was
further corroborated by frequent narrowing of GBM vessel
lumens (Fig. 1d–f), which hinders the flow of blood or perfusate.
Of note, vessels from the contralateral tumor-free hemisphere
showed no signs of insufficient perfusion or limited vascular
passability (Fig. 1g–i).
To further study transcardial perfusion deficiency in more
depth and to quantify the extent of the problem, we intravenously
(IV) injected tetramethylrhodamine (TRITC)-labeled dextran
(hydrodynamic radius ~27 nm, ref. 22) as a drug model, and
Alexa Fluor (AF) 647-labeled wheat germ agglutinin (WGA) lectin
for tracing the perfusate path (Fig. 2a–d). In order to determine
whether the inefficiency of perfusion was a result of insufficient
perfusate volume or blood coagulation, three different perfusion
protocols were employed (#1 using 20ml of perfusate, #2 using
55ml of perfusate, and #3 using 55ml of perfusate with heparin),
based on widely used approaches23–25. Images of brains from
tumor-bearing animals, which underwent this experimental
procedure, showed almost completely homogeneous AF647-
lectin mono-labeling of vessels in the tumor-free hemisphere,
suggesting full degree of transcardial perfusion in this part of the
brain (Fig. 2e–g). In contrast, a heterogeneous pattern of labeling
was observed in the GBM vasculature (Fig. 2e–j), illustrating that
the IV-injected TRITC-dextran remained in a large part of GBM
vasculature, which was not replaced by the lectin-containing
perfusate during transcardial perfusion. It was also evident
that most of the vessels were either labeled with AF647-lectin or
TRITC-dextran only, and that these mono-labeled segments were
separated by double-labeled transition zones (Fig. 2h–j). This
indicated that heterogeneity in fluorescence signals did not arise
from heterogeneous glycocalyx composition in tumor vessels,
which could also result in an incomplete lectin binding, but
instead arose from inefficient perfusion due to physical obstacles.
This pattern was consistent for three different GBM xenograft
models (G01, G06 (both primary-derived GBM cells), and U87).
To further validate this, we performed high-magnification (63×,
1.4 numerical aperture (NA)) confocal imaging of parts of the
vascular tree containing all three types of segments (Fig. 3a–c).
These images confirmed continuity between mono-labeled
vascular segments and double-labeled transition zones located in
between. Collagen IV staining confirmed that the signal from both
fluorophores was coming from within the tumor vasculature
(Fig. 3d, e). In support of this, analysis of TRITC-dextran intensity
showed significantly lower intensity levels in the transition zones
compared to mono-labeled (non-perfused) vessels (Fig. 3g, h).
This confirmed the assumption of double-labeled segments being
partly perfused vessels. To quantify the part of non-perfused and
underperfused vasculature in GBM tumors, we employed a
trainable machine learning algorithm enabling the segmentation
of different types of vasculature, with regard to the degree of
transcardial perfusion. Six regions of interest (ROIs) for each
tumor and contralateral hemisphere representing a volume of
5.97 ± 2.49 mm3 (~10% of tumor volume) for the tumor and
7.12 ± 1.36 mm3 for the contralateral hemisphere were segmented
by the trained model (Fig. 3f, i–l). The total area covered by each
vascular class was quantified and analyzed. The analysis showed
that despite large variations between individual brain tumors and
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the three different GBM cell lines, >50% of functional tumor
vasculature was not perfused properly with similar representation
of underperfused and non-perfused segments of the vascular tree
(Fig. 3m–p and Supplementary Fig. 1). At the same time, vessels of
the contralateral hemisphere showed a high degree of perfusion.
Here, the percentage of perfused vessels was always >90%, whereas
non-perfused vessels never exceeded 4% of the total vascular area.
Analysis of the proportions of different vascular classes in tumors
versus contralateral hemispheres showed statistically significant
differences in all cases, while no significant differences were found
when comparing the degree of perfusion in three different GBM
models, as well as between the three different perfusion protocols
employed (Fig. 3m–p and Supplementary Fig. 1). Importantly, the
brain tumor volume was not significantly different between the
different experimental situations that were studied (Supplemen-
tary Fig. 2d, e). Control experiments in animals not receiving
dextran injection, but with subsequent immunohistochemical
staining of collagen IV also showed only partial labeling of tumor
vessels by the lectins (Supplementary Fig. 3). While the tumor area
was characterized by the presence of both double-labeled (lectin+
collagen IV) and mono-labeled (only collagen IV) vessels, almost
all vessels in the contralateral tumor-free hemisphere appeared as
double-labeled. This indicated that dextran injection prior to the
transcardial perfusion was unlikely to cause insufficient perfusion
of tumor vasculature.
To investigate whether the limited degree of transcardial
perfusion in tumor vasculature was a unique phenomenon for
GBM, we performed the same experiments in animals bearing
flank tumors arising from two different colon cancer cell lines
(MC38 and CT26). The results showed either an almost complete
absence of perfused lectin-labeled vessels in the tumor with
predominantly non-perfused vessels in MC38 model (Supple-
mentary Fig. 4a, b) or a pattern of heterogeneous fluorescence
distribution in CT26 tumors (Supplementary Fig. 4d, e), which
was comparable to GBM tumors. Sections from the brain tissue
taken from the same animals showed complete lectin labeling of
cerebral vasculature, illustrating an otherwise efficient transcar-
dial perfusion (Supplementary Fig. 4c, f). This indicated that the
inefficiency of transcardial perfusion observed in GBM vessels
may not be restricted to GBM tumors underscoring the need for
high-resolution methods, when evaluating compound extravasa-
tion in tumor tissues in general.
Tissue sectioning exaggerates compound extravasation, favor-
ing the usage of optical tissue clearing for extravasation
detection. Aiming at making a clear distinction between the intra-
and extravascular fractions of the injected compound in GBM, we
studied the performance of conventional microscopy of tissue
sections. Examination of low-magnification confocal scans of
sectioned tumor tissue showed that many spots, comprising a
scarce pattern of dextran extravasation, were located closely to the
site of vessel segment ruptures due to tissue sectioning (Fig. 4a, b).
This observation led us to hypothesize that some extravasation
spots may be artifacts arising from sectioning of non-perfused
vessels containing fluorescent compound. High-magnification
confocal imaging confirmed the association of tissue section sur-
face and extravasation spots, hereby supporting the notion
regarding their artificial origin (Fig. 4e, f). To make sure that this
association was not a mere coincidence, but a consequence of








Fig. 1 Ultrastructural examination of GBM vasculature suggesting incomplete transcardial perfusion. Transmission electron microscopy imaging of
erythrocytes remaining in GBM vessel lumens after transcardial perfusion (a–c), compressed vessel lumens in GBM (d–f), and the lumens of normal brain
capillaries from the contralateral hemisphere (g–i). Cells composing vessel walls are highlighted with semitransparent cyan. Scale bars, 5 µm.
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the normal brain harvested without prior transcardial perfusion,
where the BBB is uniformly impermeable to 2 mDa dextran. Still,
low-magnification confocal images from the normal brain showed
dextran extravasation around larger vessels (Fig. 4c, d). High-
magnification confocal imaging of the extravasation spots con-
firmed their location near the edges of tissue sections (Fig. 4g, h)
similar to the extravasation spots observed in the tumor (Fig. 4e,
f). These observations suggest that compound extravasation stu-
died using microscopy images of conventionally prepared samples
(CPS) may be exaggerated, since a fraction of the extravasation
spots arise from sectioning artifacts.
In order to assess the level of overestimation arising from
sectioning artifacts, we compared conventional sample preparation
and optical tissue clearing, a technique, which achieves a tissue
transparency by matching the refractive indices of the tissue sample
and the solution, thus allowing large tissue volume imaging and
circumventing tissue sectioning (Fig. 4i–k). The appearance of
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Fig. 2 Measurement of perfusion degree based on fluorescently labeled probes. a Schematic representation of the experimental setup for studying the
degree of transcardial perfusion. b Schematic representation of potential experimental outcomes including full vasculature coverage by TRITC-dextran in a
situation with complete inefficiency of transcardial perfusion, c full vasculature coverage by AF647-lectin in a situation with successful transcardial
perfusion, and d heterogeneous vasculature coverage by both AF647-lectin and TRITC-dextran in a situation with incomplete perfusion of varying degrees.
e–g Representative images of coronal brain sections showing homogeneous AF647-lectin labeling of the vasculature in the tumor-free contralateral
hemisphere and heterogeneous distribution of fluorescently labeled probes in the tumor area, illustrating an incomplete perfusion of the tumors arising
from G01 (e), G06 (f), and U87 (g) cell lines. Scale bars, 1000 µm. Tumor borders are highlighted with dashed lines. h–j High-magnification images of the
selected area in e. Several examples of transition zones are marked with arrows. Scale bars, 200 µm.
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more unambiguous due to preserved structural continuity of tumor
vessels (Fig. 4l), ensuring that the registered extravasation spots
appeared as a consequence of vascular permeability in the living
animal and not due to processing artifacts. Quantification of
extravasation spots done by three independent annotators showed
a fivefold higher number of spots identified in CPS as when
compared to OCS (Fig. 4m). Seemingly, the annotated counts in OCS
had a lower variance, suggesting that extravasation in OCS is more
unambiguous to quantify (Supplementary Fig. 5). To make sure that
extravasation assessment was done in equivalent volumes of tissue,
we measured the degree of tissue volume change as a result of sample
preparation for both methods. The dehydration used as a part of
clearing process caused ~71% volume decrease, while cryopreserva-
tion in sucrose lead to ~12% volume decrease (Supplementary Fig. 6).
The sample volume was corrected accordingly. No statistically
significant difference in tumor volume was observed between the
group of CPS and OCS (Supplementary Fig. 2f).
A semiautomated machine learning-based image analysis
workflow can provide quantification and characterization of
extravasation spots in large volumes of GBM tissue. Image for
OCS provide vast amounts of data, so in order to obtain an
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efficient semiautomated method for quantification and char-
acterization of compound extravasation in large, cleared GBM
samples, we developed a machine learning-based workflow
(Fig. 5a–c) consisting of five stages: preprocessing, segmentation,
postprocessing, spot recognition, and analysis. In the preproces-
sing stage, deconvolution of both channels (TRITC-dextran and
AF647-lectin) reduced the amount of out-of-focus light and
improved the spatial resolution of the images (Fig. 5a, d). For
segmentation of extravasation spots, the model was trained on
image stacks from different tumor regions and different imaging
depths. Some particularly bright intravascular areas of TRITC-
dextran gave rise to out-of-focus light in Z-plane due to point
spread function elongation (hereafter referred to as PSF-artifacts).
Such regions were easily recognized by the human eye, but often
wrongly segmented by the initial model. Additional iterative
training minimized such misclassification. The trained algorithm
produced binary images of extravasation spots, but each spot
usually consisted of several “particles” (Fig. 5e), which was sub-
optimal for further quantification. Therefore, a postprocessing
stage consisting of a series of 2D dilations was implemented to
glue “particles” together, while a following Gaussian smoothing
brought the dilated spots to their original size and evened up their
margins (Fig. 5f). The combination of the abovementioned
transformations produced binary masks, which adequately
replicated extravasation spots in the original dataset (Fig. 5f, g).
The entire workflow is demonstrated in the Supplementary
Movie 1. The performance of the workflow was tested in two
subsets from different tumors by comparing number of extra-
vasation spots it provided versus numbers counted by the human
annotator (“ground truth”). The results showed that the workflow
provided bigger numbers in comparison to manual annotation
(Fig. 5h). The bigger number mostly arose from the false seg-
mentation of some PSF-artifacts as extravasation spots, which in
most cases did not exceed 10,000 µm3 (Fig. 5j, k). Excluding spots
smaller than 10,000 µm3 from the datasets, led to results com-
parable with human annotations (Fig. 5h). These falsely selected
spots, despite their big numbers, made only a small contribution
to the volume of extravasation (Fig. 5i). With these corrections,
the workflow enabled us to measure characteristics, such as
volume, surface area, coordinates, etc.
A semiautomated machine learning-based method allows for
vascular tree analysis in large 3D volumes. To associate extra-
vasation patterns with angioarchitecture, we developed a semi-
automated method for comprehensive analysis of the vascular
network in GBM. Similarly, to the previously described method, it
consisted of five stages: preprocessing, segmentation, postprocessing,
vessel tracing, and analysis. In the preprocessing stage, images
underwent blind deconvolution (Fig. 6a) followed by machine
learning-based segmentation of vessels (Fig. 6b). To ensure prop-
er segmentation of the vasculature in 3D space, we focused on
avoiding inclusion of out-of-focus light, spreading in Z-dimension,
into “Object” annotations. This prevented merging of vascular
borders of separate, but closely located vascular segments in the Z-
dimension. As in case of the extravasation spot analysis, we included
Z-stacks from different tumors. In the postprocessing stage, the
segmented images underwent slight 3D Gaussian smoothing for
initial removal of small isolated regions of false segmentation and
smoothing vessel surfaces. To fill the lumens of the vessels seg-
mented as hollow tubes (Fig. 6b and Supplementary Fig. 8a), we
developed a flexible workflow, which allowed for more accurate
lumen filling and adjusting the size range of the holes to be filled
(Supplementary Fig. 7a, b). This was important to avoid the filling of
spaces in between small vessels (Supplementary Fig. 7e–j). For fur-
ther smoothing of the segmented vessels, we applied median filter
(Fig. 6c). The hole-filling step was crucial for correct vessel tracing
and led to a much more precise recognition of large vessels (Sup-
plementary Fig. 8). This had a considerable effect on the extraction
of such angioarchitecture characteristics as volume fraction,
branching, length, and diameter of the vessels (Supplementary
Fig. 8g–l). However, there were still small parts of the large vessels,
which were not traced correctly, but their contribution to the total
dataset was negligible. Tracing of the vasculature provided infor-
mation on multiple parameters of the vascular tree such as vascular
volume fraction, mean vessel diameter, mean vessel length, tortu-
osity, and the number of branching points. The image transforma-
tions performed by the workflow are demonstrated in the
Supplementary Movie 2. Our workflow enabled a comprehensive
analysis of the large vasculature datasets at the resolution of single
capillaries (Supplementary Fig. 9). In combination with the extra-
vasation analysis workflow, this can provide a comprehensive
quantitative characterization of compound accumulation and its
relations with tumor angioarchitecture (Fig. 6e, f).
Simultaneous application of methods for extravasation and
vasculature analysis. Having developed and refined the metho-
dology, we decided to test its performance using TRITC-dextran
and TRITC-albumin as drug models.
For dextran extravasation analysis, two regions with apparently
different vasculature from the same tumor were selected (Supple-
mentary Fig. 10a–c) and analyzed (Supplementary Fig. 10d–g). The
analysis showed a small degree of extravasation in the form of
diffusely distributed small spots with volumes not exceeding
120,000 µm3 with no notable difference between the two regions
Fig. 3 Analysis of the fluorophores distribution in vessels after IV injection of TRITC-dextran and transcardial perfusion with AF647-lectin. a–c 3D
rendering of high-magnification confocal Z-stacks of GBM vasculature depicting different regions of vascular tree with respect to fluorophores distribution.
Green arrows mark non-perfused vessels aligned solely with signal from the remaining TRITC-dextran. Red arrows mark fully perfused vessels as
determined by the lack of signal from TRITC-dextran and the presence of signal from AF647-lectin. Blue arrows mark annotation of underperfused
transition zones. d Vasculature represented by immunostaining of collagen IV in the same region. e Overlay of images in a–d. Coloring of the vessels
segments follows the same logic as for arrows (a–c). Scale bars, 10 µm. f Diagram illustrating the principles of manual annotation of differently labeled
vascular segments for training of the machine learning algorithm. Quantification of the mean pixel intensity of the dextran signal in non-perfused and
underperfused vessels in GBM (g) (P < 0.0001, n= 30 mice, Wilcoxon signed-rank test) and in contralateral hemisphere (h) (P < 0.0001, n= 30 mice,
Wilcoxon signed-rank test). Data are presented as mean ± SD. Representative images of vessel segmentation performed by the trained model overlaid with
original image (i–k) and separately (l). Segmentation color-coding: magenta—non-perfused vessels, cyan—underperfused vessels, and orange—perfused
vessels. Scale bars, 30 µm. m–p Quantification of the degree of transcardial perfusion in GBM vessels and vessels from tumor-free contralateral
hemisphere. This was studied in animals bearing tumors arising from the G01 (m, n= 10), G06 (n, n=10), and U87 (o, n= 10). p Summary of data from all
tumor models (n= 30). Proportions of vasculature classes in tumors are significantly different from those in contralateral hemisphere for all groups (P <
0.0001, logistic regression after arcsin conversion of percentages), differences in proportions of vasculature classes in the tumors between different GBM
models are nonsignificant (P > 0.3, logistic regression after arcsin conversion of percentages). More detailed representation of the data in m–p with
individual values displayed can be found in Supplementary Fig. 1.
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IV injections and circulation 









































Fig. 4 Comparison of conventional sample preparation versus optical tissue clearing performance for the assessment of compound extravasation in
GBM. a, b Confocal images of TRITC-dextran extravasation in GBM. c, d Confocal images of TRITC-dextran extravasation in tumor-free brain regions. Scale
bars, 100 µm. e, f 3D rendering of high-magnification confocal Z-stacks of the regions marked in a and b, illustrating extravasation spots being located in a
close proximity to the sectioning-induced vessel disruption near the surface of tissue section. g, h 3D rendering of high-magnification confocal Z-stacks of
the regions marked in c, illustrating the same phenomenon in normal brain vessels. Scale bars, 20 µm. i Schematic representation of the experimental setup
employed to compare the performance of standard microscopy of conventionally prepared samples versus 3D deep microscopy of optically cleared
samples for detection and quantification of compound extravasation in GBM. j Schematic depiction of the sample excision from the brain (top), and
a bright-field image of the sample after clearing procedure (bottom). k 3D rendering of a GBM tumor in its full volume. Scale bar, 1000 µm. l 3D
rendering of a high-magnification confocal Z-stack containing a TRITC-dextran extravasation spot arising from an intact tumor vessel. Scale bar, 50 µm.
m Quantification of extravasation spots in G01 tumor samples, which were optically cleared (n= 3) or prepared conventionally (n= 5). Data are presented
as median values of the estimates made by three researchers per tumor, bars represent medians with interquartile range (P= 0.035, Mann–Whitney test).
CPS conventionally prepared samples, OCS optically cleared samples.
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(Supplementary Fig. 10h, i). Vasculature analysis allowed us to
detect and quantify differences between the two subsets on such
parameters, as volume fraction, mean vessel diameter, and
percentage of the vascular volume distribution between vessels
with different diameters (Supplementary Fig. 10j, l, m). No apparent
differences were seen in mean segment length, number of branching
points, and vessels tortuosity (Supplementary Fig. 10k, n, o). Thus,
tumor vessel permeability to TRITC-dextran was likely not linked
to any of the specific characteristics of vessel geometry measured in
this particular GBM tumor.
We then applied a combination of thresholding-based analysis
of TRITC-albumin extravasation and vasculature analysis to
inspect relations between GBM angioarchitecture and vessel
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leakage profiles were selected (Fig. 7a–c) and analyzed (Fig. 7d–g).
A high extravasation of albumin (Fig. 7h) was accompanied by a
number of differences in angioarchitecture. In the more perme-
able tumor region, mean vessel diameter was increased compared
with the less permeable region. This was supported by an
increased vascular volume fraction with bigger percentage of total
vessel volume being represented by vessels with larger diameter. It
was furthermore characterized by an increased branching and
vascular volume fraction (Fig. 7i–k, m and Supplementary
Fig. 9c). It was also characterized by a slightly increased number
of large and midsized segments, and a decreased number of small
segments (Supplementary Fig. 9d). Mean branch length and
tortuosity were comparable in the two regions (Fig. 7l, n). These
data exemplify an association of the vascular permeability degree
in GBM with some of the angioarchitecture parameters.
Discussion
Precise methods for studying compound extravasation in GBM
are important for our understanding of any given drug perfor-
mance, and, hence, its further clinical success. However, certain
features of GBM biology pose serious methodological limitations
to this. As we show in the present study, deficient transcardial
perfusion and the resulting persistence of compounds in the
vasculature of GBM, as well as in other types of tumors may
substantially impact our interpretations of drug extravasation
levels. The methods developed here not only enable a precise
measurement of compound extravasation and its spatial dis-
tribution despite these limitations, but also allow to investigate its
connections with regional pathology of tumor vasculature.
Transcardial perfusion is known to be an indispensable tool for
acute drug extravasation experiments. By removing the intra-
vascular fraction of an injected compound, it produces samples
with only the extravasated compound fraction for further
assessment2,26,27. Nevertheless, in our hands the technique fails to
remove the injected compound from almost half of the func-
tioning vessels across different GBM mouse models, regardless of
perfusion protocol. We assume that such a perfusion deficiency
can at least partly be attributed to intermittent perfusion of tumor
vasculature, which is the reason for tumor cycling hypoxia13. A
solid body of evidence from both preclinical and clinical studies
suggests that a considerable part of vessels in solid tumors have
periods of partial or complete absence of blood flow due to
obstruction and collateral shunting of blood13,28–30. The kinetics
of the process is rather complex, and consists of superimposed
cycles with different durations ranging from minutes to hours
and even days28,31–33. To mimic the situation in acute experi-
ments for compound extravasation studies, TRITC-dextran was
allowed to circulate for 3 h, so it was distributed among the
vessels with normal perfusion and in intermittently perfused
vessels with shorter perfusion cycles. During transcardial perfu-
sion, we assume that many intermittently perfused parts of the
vascular tree containing TRITC-dextran may not be accessible to
the perfusate, hereby trapping TRITC-dextran inside.
Even though the phenomenon of intermittent vascular perfu-
sion in GBM has been known for years34, it has not been con-
sidered as a factor causing serious methodological limitations in
drug delivery studies, and transcardial perfusion has been widely
employed for blood removal in tumor vessels19,21,35–37. In our
study, we quantified the part of GBM vasculature, which retains a
substantial portion of injected compound due to transcardial
perfusion deficiency and thus exaggerate compound extravasa-
tion. These findings suggest that relying only on quantitative
techniques that cannot provide a clear distinction between the
extra- and intravascular fractions of the injected compound can
lead to erroneous quantification of drug accumulation. Among
such techniques are, for example, measurements performed on
tissue lysates (e.g., ICP-MS, HPLC, etc.) or low-magnification
fluorescent measurements (e.g., small animal fluorescence ima-
ging systems)15,16,38. Microscopy, on the other hand, can provide
the necessary distinction between compound fractions17. Yet,
conventional confocal microscopy of sectioned samples will also
result in exaggerated picture of compound extravasation due to
sectioning artifacts. This could be avoided by designing the
experiments such that the time point of analysis would be long
enough to have the compound cleared from the systemic circu-
lation. However, some compounds may circulate for up to several
days39, and therefore the tumor samples taken in the end of this
period will not reflect acute compound extravasation. To over-
come these limitations, we suggest using 3D deep imaging of
optically cleared tissue. By keeping the GBM vasculature intact,
optical tissue clearing solves the problem of sectioning artifacts
due to retained compound, and provides the least distorted
results. Among other advantages of the technique is the fact that
it provides a comprehensive 3D view on the compound dis-
tribution in GBM, which is very important if the latter is het-
erogeneous, and it requires much less hands-on time for
producing an image of a given sample in comparison to imaging
of multiple tissue sections. It is also important to note that various
tissue clearing methods often use aggressive compounds40, which
can have versatile effects on the tissue, as well as extravasation
patterns, and are yet to be comprehensively studied. Such
potential effects can be limited by using optical clearing methods
with relatively mild tissue treatment like the one described in the
present study, on one hand, and, on the other, by ensuring robust
chemical fixation of the studied compound and the tissue sample
in general.
3D deep imaging of cleared samples produces massive amounts
of data, which can be fully utilized only by applying appropriate
image analysis methods40,41. However, image analysis of such
datasets is still rather challenging and highly complex, repre-
senting a bottleneck in adopting optical tissue clearing by a broad
biomedical community. Segmentation of large 3D datasets has
Fig. 5 A semiautomated machine learning-based workflow for detection and analysis of extravasation spots in 3D deep images. a 3D rendering of a
large data subset of a cleared tumor derived from an animal after IV injections of TRITC-dextran (green) and AF647-lectin (red). b Segmented and
recognized TRITC-dextran extravasation spots from the dataset in a colored independently of any attributes. c Overlay of the original dataset with the
segmented and recognized TRITC-dextran extravasation spots. Scale bars, 500 µm. d 3D rendering of tumor region containing dextran extravasation spots.
e Extravasation spots in d segmented by trained machine learning algorithm. f Segmented extravasation spots in e after postprocessing steps recognized in
Amira as separate “particles”. g Overlay of the original dataset with the segmented extravasation spots (in semitransparent cyan). Scale bars, 100 µm.
h Quantification of extravasation spots by human annotator and the developed workflow before and after correction for PSF-artifact contribution. Data are
presented as mean with individual dots representing individual samples. i Quantification of the total extravasation volume measured before and after
correction for PSF-artifact contribution. Data are presented as mean with individual dots representing individual samples. j Recognized extravasation spots
in one of the quantified samples (red spots > 10,000 µm3 and blue spots < 10,000 µm3). Scale bar, 500 µm. k High-magnification image of the region
marked in j overlaid with the original data. Segmented extravasation spots are depicted in semitransparent blue. Arrows depict falsely recognized
extravasation spots due to PSF-artifacts. Scale bar, 100 µm.
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always been problematic due to inhomogeneous levels of signal
and signal-to-background ratio throughout sample regions42,
making it very difficult to achieve satisfying results with
thresholding-based approaches. Therefore, in our workflows, we
implement the segmentation method based on deep learning,
which allows for pixel classification based on a multitude of
parameters. It is also important to note that while the exemplified
segmentation approach takes advantage of deep learning
(through employing a convolutional neural network with pre-
trained weights for feature extraction, which are used afterwards
for pixel classification by random forest of decision trees), it is not








Fig. 6 A semiautomated machine learning-based workflow for segmentation, tracing, and analysis of GBM vasculature in 3D deep images. a 3D
rendering of AF647-lectin-labeled tumor vasculature. b 3D rendering of vessel segmentation performed on the dataset in a. c 3D rendering of segmented
vessels after postprocessing steps. d 3D rendering of traced GBM vasculature with color-coding according to the vessel diameter, numbers for minimum
and maximum vessel diameter are presented in µm. Scale bars, 100 µm. e 3D rendering of AF647-lectin-labeled GBM vasculature (red) with extravasation
of TRITC-dextran (green). f Dataset from e with the extravasation spots recognized (colored independently of any attributes) and the vasculature traced.
Scale bars, 200 µm.
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scratch43. This is because the used neural network (VGG-19) is
already pretrained and training is required for the classifier only,
which needs orders of magnitude less training data compared to a
neural network. Another important issue with workflows for the
advanced analysis of large 3D datasets is their adaptability.
Implementation of such workflows usually require a certain
degree of familiarity with one or more programming languages
like Python or Matlab18,42,44. Therefore, one of our main con-
siderations for designing the workflows presented in this paper
was to ensure that they are relatively easy to apply and customize
for people, with no or little programming expertise. This was
achieved through incorporating the software with developed user
interfaces, such as ZEN Intellesis, Fiji, and Amira. Such workflows
are in general lacking in the currently available literature.
There can be different approaches to the analysis of compound
extravasation in 3D deep images and they depend on the features
of extravasation pattern. The first scenario is massive extravasa-
tion, when the compound diffusively distributes in a major part of
extravascular space like in the case of albumin extravasation in
the present study (Fig. 7a–e). In this case, thresholding-based
segmentation can be justified and does not cause serious distor-
tion of the extravasation picture. Another scenario is a less pro-
nounced compound extravasation, which is observed in the
proximity to most tumor vessels. In this case, the extravasation
pattern can be analyzed with respect to the distance it has traveled
from the vascular wall by creating distance maps45. Yet another
scenario is scarce extravasation with focal compound accumula-
tion in close proximity to the vessels as the one observed for
TRITC-dextran in the present study (Fig. 5a–g). Analysis of such
patterns requires particularly high precision, which can be
obtained by employing machine learning-based image segmen-
tation and proper image postprocessing. Furthermore, due to
high intra- and intertumoral heterogeneity in GBM46, conclusive
characterization of a compound’s ability to penetrate tumor tissue
requires extraction of multiple data points describing the extra-
vasation pattern. Together with general parameters, such as total
extravasation volume, the workflow described here allows to
extract data regarding spatial differences in compound extra-
vasation at the resolution of a single extravasation spot. At such a
level of detail, the method can detect even subtle differences in
the performance of drug delivery systems, and thus, provide
valuable information for improvement of drug delivery system
design. In addition, the method can be utilized for immune cells
tracking and analysis of pathological deposits, such as amyloid-β
(refs. 47,48).
Another important aspect of characterizing a drug delivery sys-
tem’s performance is defining the vascular properties and features
of the tumor microenvironment in the studied regions. The GBM
vasculature is remarkably heterogeneous due to two interconnected








































































































































































































Fig. 7 Method application example: relationship between GBM vasculature permeability to TRITC-albumin and the angioarchitecture. a 3D rendering
of a large data subset derived from a cleared tumor dissected from an animal after IV injections of TRITC-albumin (green) and AF647-lectin (red). Scale
bar, 500 µm. b, c 3D rendering of the regions marked in a in higher magnification. d, e TRITC-albumin extravasation segmented by thresholding after
subtraction of the segmented vasculature in the tissue subsets in b and c, the colormap reflects the density of the pixels in the extravasation mask.
f, g Traced vasculature from the subsets in b and c colored according to the vessel diameter, numbers for minimum and maximum vessel diameter are
presented in µm. Scale bars, 100 µm. h Total volume of extravasation in the tissue subsets. i Vascular volume fraction in the tissue subsets. j Mean
diameter of the vascular segments in tissue subsets. Data are presented as mean ± SD (n= 4804 and 5387 individual vessel segments). k Histogram
representing the volume fraction occupied by vessels of a certain diameter from the total vascular volume fraction in the tissue subsets. l Mean length of
the vascular segments in the tissue subsets. Data are presented as mean ± SD (n= 4804 and 5387 individual vessel segments). m Number of branching
points per volume in the tissue subsets. n Mean tortuosity of the vasculature in the tissue subsets. Data are presented as mean ± SD, (n= 4804 and 5387
individual vessel segments).
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heterogeneous tumor microenvironment46. A growing number of
studies suggest that these parameters are, at least in part, reflected
by tumor angioarchitecture. Therefore, a detailed analysis of these
parameters can provide insights into drug delivery system perfor-
mance in the different microenvironments in GBM51. At the early
stages, GBM cells co-opt relatively small vessels52. Subsequently,
vessels in the vicinity to the GBM cells become larger than average
capillaries in the normal brain and more permeable due to tumor
cells displacing astrocytic end feet52,53. With the rapid growth of the
tumor bulk, some regions continue its invasive growth by hijacking
normal brain vessels, while other regions provide vascularization by
inducing intensive sprouting angiogenesis, a process dependent on
vascular endothelial growth factor (VEGF) signaling54. Such regions
are characterized by high vascular permeability, abundant areas of
hypoxia, necrosis, and a pronounced mass effect20,54. At the level of
the angioarchitecture, these conditions are reflected by increased
vasculature volume fraction and vessel diameter20. As hypoxia
increases, leading to an increase in VEGF signaling, vessels become
more permeable, which is reflected by the diameter increase at the
level of angioarchitecture20,55. It is important to emphasize that
clinical data also show significant correlation between vessel dia-
meter, BTB permeability, and tumor grade56. Obviously, more
correlative studies are needed to establish connections between the
numerous characteristics of angioarchitecture and other aspects of
tumor biology. Nevertheless, angioarchitecture analysis has a big
potential for becoming a very useful technique also in clinical
practice. Not only can it improve biopsy phenotyping57, but it may
also advance noninvasive tumor evaluation, especially with further
improvement in resolution of medical imaging techniques58,59.
Analysis of GBM angioarchitecture alongside with extravasation
assessment poses a number of challenges and calls for a dedicated
approach. While thinning operations, used for skeletonization of 3D
networks, require all vessels to be segmented as filled tubes60,
labeling of vessel lumens in GBM is practically impossible in
experiments for extravasation analysis. Due to deficiency of trans-
cardial perfusion, the labeling agent has to be introduced by IV
injection, and, as our experiments showed, after 1 h of circulation,
AF647-lectin reached all GBM vessels accessible for TRITC-dextran
during 3 h of circulation. The need for a long circulation time of the
vascular labeling agent makes it impossible to employ gelatin-based
vessel labeling strategies, which provide staining of vascular
lumen61,62. Also, due to the BTB leakiness, the vessel labeling agent
must have high affinity to the internal vascular surface to ensure that
signal coming from vasculature is much stronger than the signal
from its extravasated fraction. Such a labeling strategy, however,
cannot provide vessel lumen labeling in the large perfused tumor
vessels, which are therefore segmented as hollow tubes. Filling of
such vessels has to be done at the image processing stage, but the
usage of morphological closure tools (dilation/erosion operations) is
limited due to high variability of GBM vessel size (Fig. 7j–l and
Supplementary Fig. 9)63. Furthermore, the usage of an alternative
option, such as a standard nonadjustable hole-filling tool, which fills
all empty spaces surrounded by signal from four sides in 2D space,
can affect the regions with dense capillary networks (Supplementary
Fig. 7e, g, i). We addressed the abovementioned challenges by uti-
lizing the high precision of machine learning-based segmentation,
which minimizes the need for postprocessing operations and
developed adjustable Fiji-based method for vessel lumen filling.
In conclusion, we showed that transcardial perfusion deficiency
in tumor vessels has major implications for the assessment of
compound extravasation in GBM, and that many of currently used
methods would overestimate extravasation. We demonstrated how
3D deep imaging of cleared samples is not subjected to the lim-
itations of vascular underperfusion and can robustly assess drug
delivery system performance. We also developed user-friendly
complementary image analysis techniques allowing to characterize
compound extravasation patterns in large 3D datasets and correlate
it with angioarchitecture parameters. We believe that this can
substantially improve the assessment of GBM targeting and provide
a deeper understanding of the drug distribution in tumor tissue,
which is much needed for fighting GBM.
Methods
GBM cell lines and culturing. For the present study, three GBM cell lines of
different origins were used: G01, G06, and U87MG. Primary GBM cells (G01 and
G06) were obtained from freshly resected tumor tissue obtained from the
Department of Neurosurgery at Copenhagen University Hospital in accordance
with the guidelines outlined by the Danish Ethical Committee and the Danish Data
Protection Agency (H-3-209-136_63114), including informed consent prior to
surgery. The G01 and G06 cell lines were passaged subcutaneously in the flanks of
NOG mice as outlined in the Danish Welfare Law on Animal Experiments Act no.
1306, protocol: 2012-15-2934-00636. Single cells were isolated from xenografts
using the dissociation system (Worthington Biochemical Corporation,
#LK003150), according to manufacturer’s instructions. Isolated cells were grown in
Neurobasal-A medium supplemented with B27 minus vitamin A (Thermo Fisher
Scientific, #12587-010), epidermal growth factor (20 ng/ml, R&D systems, #236-
EG-01M), fibroblast growth factors (20 ng/ml, R&D systems, #4114-TC-01M),
GlutaMAX (Thermo Fisher Scientific, #35050-038), and antibiotics (Thermo Fisher
Scientific, #15140122). Both lines were routinely authenticated using ATCC STR
profiling. U87MG cells (ATCC and HTB-1) were grown in Dulbecco’s Modified
Eagle medium (DMEM) with GlutaMAX (Thermo Fisher Scientific, #10566032)
supplemented with fetal calf serum (100 mg/ml) and antibiotics (Thermo Fisher
Scientific, #15140122). All cell lines were routinely tested for mycoplasma.
GBM orthotropic xenografts. Female NMRI-nude mice aged 7–9 weeks (Taconic
Biosciences, # NMRINU-F) were inoculated orthotopically with GBM cells grown
as neurospheres in Neurobasal-A medium (12349-015, Invitrogen) supplemented
with B27 minus vitamin A (Invitrogen, #12587-010), epidermal growth factor
(20 ng/ml), fibroblast growth factors (20 ng/ml), GlutaMax (Invitrogen, #35050-
038), and antibiotics (Invitrogen, #15140-122). Prior to inoculation, the GBM
neurospheres (G01, G06) or GBM cells grown as monolayer (U87MG) were treated
with TrypLE (Thermo Fisher Scientific, #12604013) to generate a single cell sus-
pension and resuspended in PBS reaching the concentration of 5000 cells/µl (G01
and G06) and 20,000 cells/µl (U87MG). Animals were anaesthetized with intra-
peritoneal injection of Hypnorm/Midazolam mixture and placed in the stereotaxic
frame. The surgical area was locally anaesthetized by subcutaneous injection of
Marcain and rinsed with alcohol. An incision was made in the scalp and a burr hole
drilled 1 mm anterior, 1.6 mm laterally from Bregma. The needle of a Hamilton
syringe was first positioned at the depth of 2.5 mm from dura and then moved
0.5 mm upward creating a small void preventing the backflow of the cell suspen-
sion. A total of 10,000 (G01 and G06) or 200,000 (U87) cells were inoculated into
the striatum using a micro pump (World Precision Instruments, UMP3) running
at the speed of 1 µl/min. As an additional preventive measure for avoiding backflow
of the cells, the needle was removed from the inoculation site 3 min after the end of
injection. Tumor progression was monitored with T2-weighted MRI (Bruker,
BioSpec 7T, acquisition software: Paravision 360) and a body weight of animals was
measured three times a week. The criteria for performing experimental procedures
were at least 3 weeks of tumor growth and a tumor volume exceeding 10 mm3.
Symptoms such as a body mass drop of >15%, paresis, plegia, or hypoactivity were
criteria for endpoint. Volumes of all tumors used for the present study are
represented on Supplementary Fig. 2g. Tumor volume was measured with Horos
3.3.5 (Horos Project) on the scans taken within 24 h before experimental proce-
dure. All experimental procedures involving animals were conducted under the
approval of institutional boards for ethical use of experimental animals (Copen-
hagen University and Technical University of Denmark) and Danish Animal
Experiments Inspectorate (license #: 2020-15-0201-00482). The experiments were
performed in accordance with relevant guidelines and regulations (EU directive
2010/63/EU and relevant local additions to this directive).
Syngeneic colorectal cancer models. Two types of tumors models (arising from
CT26 and MC38—syngeneic colorectal cancer cell lines) established in 7–10-week-
old female BALB/cJRj and C57BL/6JRj mice (Janvier). CT26 cells were cultured in
RPMI (Thermo Fisher Scientific, #61870044) with fetal bovine serum (100 mg/ml,
Thermo Fisher Scientific, #10500064), GlutaMAX (2 mM), and antibiotics. MC38
cells were cultured in DMEM with fetal bovine serum (100 mg/ml), GlutaMAX
(2 mM), and antibiotics (Thermo Fisher Scientific, #15140122). At the day of
inoculation, mice were anaesthetized with sevoflurane and 300,000 cells were
injected into the flank region. CT26 cells were inoculated in serum-free RPMI and
MC38 cells were inoculated in serum-free DMEM. Tumor volumes were calculated
as length × width2 × 0.5 based on digital caliper measurements.
Electron microscopy. Tumor-bearing mice were transcardially perfused with PBS
followed by 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (Caco; EMS,
#11653). After overnight postfixation, samples were taken from the tumor and
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contralateral hemisphere using a biopsy needle (diameter: 1 mm). The samples
were washed in 0.15 M Caco buffer containing 2 mM calcium chloride three times
(first time—overnight at 4 °C, and two times at room temperature (RT) 15 min
each) and postfixed in the solution of 2% osmium tetroxide (Sigma-Aldrich,
#75632) and 1.5% potassium ferrocyanide (Sigma-Aldrich) in 0.15M Caco buffer
(pH 7.2) for 20 min at RT. After 3 washes (5 min each at RT) in distilled water,
samples were immersed in 1% thiocarbohydrazide (Sigma-Aldrich, #88535) solu-
tion in distilled water. After 30 min, tissue was washed 3 times with distilled water
and left in 2% osmium tetroxide for 1 h. After 3 washes with distilled water, uranyl
bloc stain was performed by immersing the samples in 1% uranyl acetate (EMS,
#22400) at 4 °C overnight. Then, samples were washed and immersed in the
solution of 0.02M lead nitrate (Sigma-Aldrich, #467790) in 0.03 M sodium
aspartate for 30 min at 60 °C. Afterwards, the samples were washed and dehydrated
in ethanol solutions 70% (2x), 90% (2x), 96% (2x), 100% (2x+ 2x anhydrous
ethanol) 7 min each step at RT and immersed in propylene oxide 100% (Sigma-
Aldrich, #20401) 2x. The samples were then consecutively moved to 25%, 50% and
75% solutions of epon hard (TAAB, #812 resin T031) in propylene oxide (each
immersion step lasting 30 min) and left overnight in 100% epon hard. For poly-
merization, epon-embedded samples were left at 60 °C for 24 h. Ultrathin sections
were cut and imaged using transmission electron Microscopy (Philips, CM100).
Evaluation of transcardial perfusion degree in tumor vasculature
Perfusion. Tumor-bearing mice received IV bolus injections of lysine-fixable
TRITC-conjugated 2 mDa dextran solution (50 µg/g, Thermo Fisher Scientific,
#D7139). The IV injection flow rate was kept <1 ml/min. After 3 h of TRITC-
dextran circulation, mice were anaesthetized with sevoflurane and transcardially
perfused. In order to remove the major fraction of erythrocytes, the mouse was first
perfused with 5 ml of PBS, followed by the perfusion of 5 ml AF647-conjugated
WGA (100 µg/ml, Thermo Fisher Scientific, #W32466) in PBS aimed at marking
the intravascular path of the perfusate. The next step of the perfusion procedure
varied depending on the perfusion protocol used: in protocol #1—perfusion of
10 ml PBS, in protocol #2—perfusion of 45 ml PBS, and in protocol #3—perfusion
of 45 ml PBS with heparin (10 i.u./ml, LEO Pharma). In order to standardize
perfusion flow rate, the flow of the perfusate was driven by a syringe pump
(Harvard Apparatus, #0-2001) running at a flow rate of 8 ml/min. The flow rate
was selected to match the cardiac output of the mouse64 and was proven effective
for perfusion of the normal brain vessels (Figs. 2e–j, 3m–p, and Supplementary
Fig. 1). The only interruption of the perfusion was a short break for manually
injecting the lectin solution to the perfusion system.
Tissue processing and imaging. After perfusion, brains were dissected, immersed
into frozen section medium (Leica Biosystems, #3801480), and snap-frozen in
liquid nitrogen-cooled isopentane (Sigma-Aldrich, #NC0948209). 60 µm coronal
sections were obtained using a cryostat (Leica Biosystems, 1850 UV). In order to
cover different tumor regions, six sections were taken from each tumor. First and
last sections represented most anterior and posterior tumor parts. The size of the
interval for section collection was constant and was calculated based on sagittal
MRI scans. Sections were mounted with DAPI-containing mounting media
(Abcam, #ab104139) and imaged with a slide scanner using a 10× objective with
0.45 NA (Zeiss Microscopy, Axio Scan.Z1, camera: AxioCam MRm, acquisition
software: ZEN Blue 2.3).
Image processing and analysis. Slide-scanned images were stitched using ZEN Blue
3.0 software (Zeiss Microscopy). For each section, ROIs were selected: tumor (as
defined by the nuclear pattern in DAPI staining) and contralateral hemisphere
avoiding the inclusion of the section margins. For image segmentation, machine
learning-based software was used (ZEISS Microscopy, ZEN Intellesis). The model
was trained to recognize four main classes: non-perfused vessels, underperfused
vessels, perfused vessels, and background. Training annotations were done in
accordance with the intravascular fluorescence signal: vessels stained only with
TRITC-dextran were annotated as non-perfused, vessels stained with both TRITC-
dextran and AF647-lectin were annotated as underperfused, and vessels stained
only with AF647-lectin were annotated as perfused vessels. The remaining part of
the image was annotated as background. The annotation principle and the per-
formance of the trained model are illustrated on Fig. 3f, i–l. It is worth emphasizing
that the training model was specifically trained to recognize the areas of dextran
extravasation as a part of background so these areas were not counted as non-
perfused vessels. The model performance was tested in all datasets and training
iterations continued until satisfactory segmentation was achieved for most of the
images. If the selection was done unsatisfactory, the basic model was refined for
particular type of samples like the ones with extraordinary high level of signal from
extravasated TRITC-dextran (Supplementary Fig. 11), in order to cope with the
generalization problem43. Training dataset for the main model consisted of five
large 2D images acquired with slide scanner, which were partly but extensively
annotated. For modification of the model mentioned above, certain training images
were replaced by the annotated images containing instances of extensive dextran
extravasation providing high background levels. In images where it was not pos-
sible to achieve correct segmentation of some very high-intensity TRITC-dextran
leakage spots without affecting the segmentation of other elements, regions con-
taining these spots were deleted (Supplementary Fig. 11a, b).
As a quantitative output for the perfusion degree analysis, we used areas
covered by each vascular class. Percentage of each class was calculated from total
vasculature area for each section, and a weighted average was calculated for the
whole tumor based on the area of each section.
Three mice bearing MC38 flank tumors (tumor volume: 152, 102, and
118 mm3) and two mice bearing CT26 flank tumors (tumor volume: 106 and
93 mm3) underwent experimental procedure described as protocol 3 with
subsequent dissection of the tumor tissue and brain sample. Samples were further
handled and imaged in the same way as GBM tumor samples.
Additional controls. To make sure that injected TRITC-dextran molecules are not
the reason for the low transcardial perfusion degree in GBM vasculature, tumor-
bearing mice underwent the same perfusion procedure as in protocol 3, but without
TRITC-dextran injection and with following immunohistochemical staining of
collagen IV.
Immunohistochemistry. Coronal sections obtained from mice that underwent
either standard experimental procedure for transcardial perfusion assessment as
described above, or the one without TRITC-dextran injection were fixed with 4%
methanol-free formaldehyde (Thermo Fisher Scientific, #28908) for 1 h. After three
PBS washing steps (5 min each), the sections were blocked with a solution con-
sisting of 5% donkey serum (Millipore, #S30-100ML) and 0.3% Triton X-100 in
PBS for 3.5 h. After blocking, the samples were incubated with primary antibodies
—goat anti-type IV collagen (1:500; SouthernBiotech, #1340-01) overnight at 4 °C.
After three PBS washing steps, the sections were incubated with secondary anti-
bodies—donkey anti-goat AF488 (1:500; Thermo Fisher Scientific, #A-11055) and
Hoechst (Thermo Fisher Scientific, #H3570) for 4.5 h at RT. Afterward, the sec-
tions were washed and mounted with ProLong™ Diamond Antifade Mountant
mounting media (Thermo Fisher Scientific, #P36970). Mounted sections were
imaged with slide scanner as described above. High-magnification images were
obtained using a confocal microscope using 63×, NA 1.4 objective (Zeiss Micro-
scopy, LSM 780).
Comparison of conventional tissue preparation versus tissue clearing for
extravasation assessment
Experimental procedure and sample preparation. G01-bearing mice were IV-
injected with TRITC-dextran, as previously described. After 2 h of TRITC-dextran
circulation, mice were IV-injected with 200 µl AF647-conjugated WGA (1 µg/µl in
PBS, Thermo Fisher Scientific, #W32466) to label the vasculature. After 1 h of
WGA circulation, the animals were transcardially perfused with 30 ml of PBS
followed by 20 ml of 4% methanol-free formaldehyde solution (Thermo Fisher
Scientific, #28908). After perfusion, the brains were dissected and postfixed over-
night at 4 °C. Postfixed brains were separated into two groups: one undergoing
conventional sample preparation and another undergoing optical clearing. Samples
from CPS group underwent cryopreservation with 15 and 30% sucrose solutions at
4 °C (steps duration: until brain’s sinking). Cryopreserved samples were immersed
into frozen section medium (Leica Biosystems, #3801480) and snap-frozen in
liquid nitrogen-cooled isopentane. A total of 60 µm coronal sections were obtained
using cryostat (Leica Biosystems, 1850 UV) and mounted in ProLong™ Diamond
Antifade Mountant (Thermo Fisher Scientific, #P36970). To obtain samples for
OCS group, tumors with surrounding brain tissue (to prevent damaging tumor
vessels) were carefully excised. None of the sample dimensions exceeded 5 mm.
The clearing technique used for OCS was based on the method developed by
Klingberg et al.65. This approach was chosen to avoid substantial tissue delipida-
tion, which could lead to an anisotropic sample shrinkage due to a pronounced
difference in lipid content between the GBM and the normal brain tissues66,67. This
was important when comparing OCS and sectioned samples, since the latter did
not undergo delipidation. The excised samples underwent step-by-step serial
dehydration in ethanol (30% for 2 h, 50% for 2 h, 70% for 2 h, 96% for 2 h, 100%
overnight, and 100% for 2 h). After dehydration, the samples were incubated in
ethyl cinnamate (Sigma-Aldrich, #112372) for a minimum of 6 h and were imaged
shortly after the end of the last incubation step. Experimental protocols are illu-
strated on Fig. 4i.
Measurements of tissue volume change due to sample processing in optically cleared
versus conventionally prepared samples. NMRI-nude mice were perfusion-fixed as
described above, and the brains were postfixed overnight. After postfixation, six
cylinder-shaped samples were taken using biopsy needles (diameter—3 mm). The
samples were separated in the same groups and underwent the same processing
steps, as described above. Before and after undergoing the preparation procedure,
samples were imaged with a stereomicroscope (Zeiss Microscopy, Stemi 508; Sup-
plementary Fig. 6a–d). The dimensions of imaged cylinders were measured in Fiji
software68 and volumes calculated to establish the correction factor (CF) for tissue
volume change. CF for volume change was calculated using the following formula:
CF ¼ medðOCSÞ medðCPSÞ;
where: med(OCS)—median value of volume change percentage from the group of
optically cleared samples and med(CPS)—median value of volume change per-
centage from the group of conventionally prepared samples.
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Imaging, image processing, and image analysis. Fluorescently labeled samples
from both groups were imaged with a confocal laser scanning microscope using a
10× objective with 0.3 NA (Zeiss Microscopy, LSM 780, acquisition software: ZEN
Black 2012 SP 5). Taking into account potential differences in signal intensity
arising from difference is sample preparation methods, the microscope acquisition
parameters (including Z-correction) were set to capture the intensity just below the
saturation limit. Voxel size was equal to 0.69 µm × 0.69 µm × 3 µm. Total imaging
time of OCSs (unidirectional scan) was on average ~15 h. The size of the datasets
from OCS (two channels) was on average ~60 GB. Images from CPS samples were
stitched using ZEN Blue 3.0 software. Images from OCS underwent blind decon-
volution in Amira 6.5 software (Thermo Fisher Scientific) and were stitched in Fiji,
using Grid/Collection stitching plug-in69. For further quantification of dextran
extravasation spots number, peripheral regions of the tumors were selected. In case
of cleared samples, regions for analysis were selected from the upper quarter of the
stack, characterized by the highest image quality. The volume of selected datasets
was equivalent to more than 4 mm3 of postfixed tissue when corrected for tissue
volume change. Numbers of dextran extravasation spots per tumor volume were
independently calculated by three annotators and the resulting medians of the
counts were reported.
For visualization of sectioning artifacts in the normal brain region, NMRI-nude
mouse was injected with TRITC-dextran and AF647-lectin, as described above. In
order to maintain dextran molecules in the healthy vasculature, animal was not
perfused, but decapitated under sevoflurane anesthesia. Following steps of tissue
preparation were identical to those for CPS group. High-magnification images of
extravasation spots were obtained with a confocal microscope using a 63×, NA 1.4
objective (Zeiss Microscopy, LSM 780).
Detection and analysis of extravasation in cleared tissue samples
TRITC-dextran extravasation analysis. Deconvolved images of optically cleared
GBM samples underwent Gaussian blurring (σ= 1.3; here and below sizes of all
filters are presented for the images not calibrated to the actual physical size) in ZEN
Blue 3.0 and were segmented with ZEN Intellesis software (Zeiss Microscopy). The
model was trained to recognize dextran extravasation spots and classify the rest of
the image as background. The training dataset consisted of five different image
stacks, each containing on average 13 partly annotated images. The segmentation
output (3D binary masks) were then imported to Fiji and underwent postprocessing,
in order to connect all parts of the segmented extravasation spot together. Post-
processing consisted of four consecutive 2D dilation steps followed by 3D Gaussian
filtering (σ of x,y,z= 3) and thresholding (pixel intensity: 50–255). Afterward, images
were imported to Amira 6.5 and extravasation spots were recognized and measured
using Label analysis module. Spots smaller than 10,000 µm3 were excluded from the
analysis. For method validation, two image subsets 2 mm3 in volume were selected
from two different tumors, number of extravasation spots was counted manually by
human annotator and by using developed workflow.
Detection and analysis of albumin extravasation in cleared tissue samples.
G01 tumor-bearing mouse underwent the same experimental procedure as for
dextran extravasation studies, but instead of TRITC-dextran, TRITC-conjugated
albumin (50 µg/g, Thermo Fisher Scientific, #A23016) was injected. Tissue samples
were optically cleared and imaged, as described above. Deconvolved images of
TRITC-albumin channel in the tumor were thresholded (pixel intensity: 60–255).
AF647 (lectin) channel of the same region underwent image processing steps
described below (all before tracing step), and was subtracted from the thresholded
TRITC-albumin channel to avoid contribution of intravascular albumin fraction to
the measured volume. After subtraction, extravasated volume was measured in Fiji.
Tracing and analysis of the vascular network in cleared tissue samples. The
AF647 channel from deconvolved images of cleared tissue samples was imported to
ZEN Blue 3.0 and segmented with Zeiss ZEN Intellesis software. Models for seg-
menting tumor vasculature and normal brain vasculature were trained separately.
Training dataset for model used for segmentation of tumor vasculature consisted of
five image stacks each containing on average 18 partly annotated images. In case of
the model for normal brain vasculature segmentation, four image stacks with on
average three partly annotated images each comprised training dataset. Segmented
3D binary masks of the vasculature were imported to Fiji and underwent post-
processing. Postprocessing included Gaussian smoothing (σ= 0.9) followed by
thresholding (pixel intensity for all tumor datasets: 170–255, and for normal brain
dataset: 105–255) followed by filling the lumens of vessels segmented as hollow
tubes, with subsequent median filtering (radius equal 3 for tumor datasets and 1 for
normal brain dataset). For vessel lumen filling, the Fiji plug-in “Analyze Particles”
was applied on Gaussian-smoothened 3D binary masks of the vessels. The plug-in
was set to provide binary masks, which corresponded to the lumens of hollow
vessels in a given optical section, since those were recognized as 2D particles by the
plug-in. By adding these masks and the vessel masks produced by Intellesis, lumen
filling was achieved in a given plane. To maximize filling of vascular lumens the
procedure was done consecutively on the Z-stack sliced in XY, YZ, and XZ planes
in two iterations. Sequence of operations for achieving lumen filling is depicted in
detail in Supplementary Fig. 7a. Postprocessed datasets were imported to Amira 6.5
and the vasculature was traced by the AutoSkeleton module employing method
developed by Fouard et al.70. Vascular geometry was calculated in Euclidean space
through calculation of the Euclidean distance map, and vascular segments shorter
than 10 µm were excluded from analysis. An underestimation of vessel diameter
produced by the method was measured on 100 vessel segments with different
diameter. These measurements were further used for the curve fitting with
exponential decay function, which allowed to calculate the CF with the following
formula:
CF ¼ ðY0 PlateauÞ ´ expðK ´MDÞ þ Plateau
where: Y0= 3.7, Plateau= 1.3, K= 0.5861, MD—initially measured diameter of a
vessel segment.
For correcting initial diameter measurements, they were multiplied by the value
of the CF.
Of note, in the vasculature spatial graphs shown in the figures and
Supplementary Movie 2, were not scaled 1:1 with regard to the vessel diameter, in
order to provide a better overview on the obtained spatial graph.
Software for machine learning-based segmentation and workstation char-
acteristics. The tool used for image segmentation in the present study is the
Python-based deep learning software package ZEN Intellesis (Zeiss Microscopy)71.
The software allows for a supervised training of the pixel classifier on the micro-
scopy images. For feature extraction the software employs very deep convolutional
neural network the VGG-19, which was adopted by Zeiss Microscopy from the
work of Simonian and Zisserman72 without any considerable changes or additional
training. According to the authors, the training of the neural network was done
using mini-batch gradient descent as optimization algorithm for multimodal
logistic regression objective, the batch size was 256 and the number of epochs was
74, for more details please refer to the original work72. From the third layer of the
VGG-19, 256 features were extracted and used to train random forest classification
algorithm73. For the structured predictions, conditional random fields74 were
applied for all datasets except normal brain vasculature segmentation of which was
satisfactory with basic settings.
The workstation used for image analysis had following characteristics, CPU:
dual Xeon processors E5-2670, 2.6 GHz (96 GB RAM) and GPU: GeForce RTX
2080Ti (11 GB RAM).
Statistics and reproducibility. Statistical analysis was mainly performed using
GraphPad Prism 8.1.1 (GraphPad software). To estimate the difference between
two unpaired groups, the two-tailed Mann–Whitney U test was used. For the
comparison of paired groups, the two-tailed Wilcoxon signed-rank test was used.
To compare the proportions of different vascular classes, we initially arcsine
converted the percentages and performed logistic regression to assess changes
(done using R for Windows, version 2.12.1). A P value <0.05 was considered
statistically significant, and the degree of significance is represented as follows:
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Sample sizes are specified
in the figure legends containing graphs where statistical information is derived. All
data represented in the main figures as graphs can be found in the form of tables in
Supplementary Data 1.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data underlying graphs presented in the main figures are available in the form of excel
sheets as Supplementary Data to the present paper. Other data are available upon
reasonable request by contacting the corresponding authors.
Code availability
Code for image postprocessing is available upon request by contacting the corresponding
authors.
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